PRNIX
Price
$34.39
Change
+$0.16 (+0.47%)
Updated
Aug 10 closing price
Net Assets
575.83M
VMVAX
Price
$107.59
Change
+$0.29 (+0.27%)
Updated
Aug 10 closing price
Net Assets
38.61B
Interact to see
Advertisement

PRNIX vs VMVAX

PRNIX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
PRNIX vs. VMVAX commentary
Aug 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRNIX is a Buy and VMVAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 38.6B vs. PRNIX (576M). VMVAX pays higher dividends than PRNIX: VMVAX (1.81) vs PRNIX (1.25). PRNIX was incepted earlier than VMVAX: PRNIX (29 years) vs VMVAX (15 years). PRNIX (0.84) is less costly to investors than VMVAX (0.07). PRNIX is a more actively managed with annual turnover of: 57.00 vs. VMVAX (23.00). VMVAX has a lower initial minimum investment than PRNIX: VMVAX (3000) vs PRNIX (1000000). VMVAX annual gain was more profitable for investors over the last year : 23.54 vs. PRNIX (20.73). VMVAX return over 5 years is better than : 44.37 vs. PRNIX (-6.64).
PRNIXVMVAXPRNIX / VMVAX
Total Expense Ratio0.650.07929%
Annual Report Gross Expense Ratio0.840.071,200%
Fund Existence29 years15 years-
Gain YTD19.39316.883115%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets576M38.6B1%
Annual Yield % from dividends1.251.8169%
Returns for 1 year20.7323.5488%
Returns for 3 years22.4048.1746%
Returns for 5 years-6.6444.37-15%
Returns for 10 years42.09126.2633%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WBIGX29.42N/A
N/A
William Blair International Growth N
PNSCX76.26N/A
N/A
Putnam Small Cap Growth C
ASGTX4.95N/A
N/A
Transamerica Small Cap Growth A
MLVTX19.16N/A
N/A
MFS Low Volatility Equity R6
RGLFX32.04-0.04
-0.12%
American Funds Global Insight R-5